Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Farid Esfahani"'
Autor:
Andrew Gomori, Karen Ethans, Mahmoud Torabi, Malcolm Doupe, Dana Turcotte, Mike Namaka, Farid Esfahani, Katie Galloway
Publikováno v:
Pain Medicine. 16:149-159
Background Neuropathic pain (NPP) is a chronic syndrome suffered by patients with multiple sclerosis (MS), for which there is no cure. Underlying cellular mechanisms involved in its pathogenesis are multifaceted, presenting significant challenges in
Autor:
Andrew Gomori, Meghann Klowak, Michael Prout, Farid Esfahani, Michael Namaka, Romeo Hizon, Amy Grossberndt, Christine Leong, Michael R. Mulvey, Loressa Klassen, Maria Melanson, Malcolm Doupe, Aneri Gupta, Emma E. Frost
Publikováno v:
Multiple Sclerosis Journal. 17:397-403
Background: Staphylococcus aureus may produce superantigens that can non-specifically activate CD4+ cells to potentially target the myelin basic protein. Objective: This study examined the association between individuals with multiple sclerosis (MS)
Autor:
Michael Prout, Michael Namaka, Andrew Gomori, Meghann Klowak, Maria Melanson, Emma E. Frost, Colin R. Gramlich, Lisa Wong, Malcom Doupe, Amy Grossberndt, Christine Leong, Farid Esfahani, Josee-Anne Le Dorze
Publikováno v:
International Journal of Neuroscience. 120:631-640
Fatigue and cognitive deficits are common symptoms affecting patients with multiple sclerosis.The effects of interferon beta on fatigue and cognitive deficits were assessed in 50 patients with relapsing multiple sclerosis (recruited at a single cente
Autor:
Mike Namaka, Andrew Gomori, Farid Esfahani, Josee-Anne Le Dorze, Dana Turcotte, Emma E. Frost
Publikováno v:
Expert Opinion on Pharmacotherapy. 11:17-31
In recent times, our knowledge of cannabinoids and the endocannabinoid system has greatly advanced. With expanding knowledge, synthetic cannabinoids - including nabilone, dronabinol and a combination of synthetic Delta9-THC and cannabidiol - have bee
Autor:
Michael Namaka, Howard Intrater, Meghann Klowak, Amy Grossberndt, Christine Leong, Andrew Gomori, Farid Esfahani, Dana Turcotte
Publikováno v:
The Consultant Pharmacist. 24:885-902
OBJECTIVE The purpose of this review is to provide an update of the neuropathic pain treatment algorithm previously published by Namaka et al. in 2004. This algorithm focuses on the strategic incorporation of the latest pain therapies while providing
Autor:
Josee-Anne Le Dorze, Michael Prout, Michael Namaka, Christine Leong, Farid Esfahani, Mike Limerick, Emma E. Frost
Publikováno v:
Clinical Medicine Insights: Therapeutics, Vol 2 (2010)
Objective To provide a comprehensive overview on the emerging treatments used for the treatment management of multiple sclerosis (MS). Data Sources PubMed, MEDLINE, Cochrane, and Toxnet databases were used to conduct all comprehensive literature sear
Publikováno v:
European Journal of Pain Supplements. 5:240-241
Autor:
Karen Ethans, Andrew Gomori, Mahmoud Torabi, Malcolm Doupe, Farid Esfahani, Katie Galloway, Michael Namaka, Dana Turcotte
Publikováno v:
World Journal of Anesthesiology. 3:181
AIM: To compare the effectiveness and tolerability of paroxetine vs pregabalin for the management of multiple sclerosis(MS)-induced neuropathic pain(NPP).METHODS: A randomized, flexible-dose open-label 8-wk study involving 21 relapsing-remitting MS p